Tandem Diabetes Care Inc TNDM

US Health Care
$16.57 β–² +0.91% (+$0.15)
⬆️ Above Yest. High
Open $16.24
Prev Close $16.42
Day Range $15.87 – $16.65
52W Range $11.46 – $29.65
Market Cap $1.15B
Beta 1.61
EPS (TTM) $-0.93

πŸ“‹ Company Profile

IndustryHealth Care
CountryUS
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD
IPO Date2013-11-13
Shares Out.68,530,000
Websitetandemdiabetes.com/ β†—
Phone13026365400
Employees2,500
Revenue$254.6M
Gross Profit$144.8M
Net Income-$21.2M
Free Cash Flow-$105.2M
Total Assets$1.15B
Total Liabilities$1.02B
Equity$130.4M
About Tandem Diabetes Care Inc

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.

Tandem Diabetes Care Inc is a publicly traded company under the ticker symbol TNDM on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.

πŸ“Š Analyst Ratings

29 analysts (2026-09-01)

Strong Buy 7
Buy 11
Hold 11

πŸ“° Latest News for TNDM

πŸ‘₯ Related Stocks